T. Rowe Price Associates’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.29M | Buy |
|
|||||
|
2025
Q2 | $526K | Buy |
|
|||||
|
2025
Q1 | $326K | Buy |
|
|||||
|
2024
Q4 | $388K | Buy |
|
|||||
|
2024
Q3 | $477K | Buy |
|
|||||
|
2024
Q2 | $343K | Buy |
|
|||||
|
2024
Q1 | $237K | Buy |
|
|||||
|
2023
Q4 | $184K | Buy |
|
|||||
|
2023
Q3 | $290K | Buy |
|
|||||
|
2023
Q2 | $301K | Buy |
|
|||||
|
2023
Q1 | $254K | Buy |
|
|||||
|
2022
Q4 | $129K | Buy |
|
|||||
|
2022
Q3 | $151K | Buy |
|